Zobrazeno 1 - 10
of 6 757
pro vyhledávání: '"35"'
Publikováno v:
Japanese Journal of Clinical Oncology. 50:1195-1200
Objectives To evaluate computed tomography findings and assess the clinical course of patients with pulmonary epithelioid hemangioendothelioma. Methods Patients diagnosed with pulmonary epithelioid hemangioendothelioma at our institution between 2000
Publikováno v:
IUBMB Life. 72:957-964
Interleukin polymorphisms might influence predisposition to lung cancer (LC), but the results of already published studies regarding the relationship between interleukin polymorphisms and LC were still controversial and ambiguous. So the authors desi
Autor:
Yiwei Wang, Xiaoyan Li, Siwen Gu, Wanna Chen, Yun Cao, Qiang Zou, Yiting Jin, Jing He, Mingxia Zhou, Xiuping Liu, Chengyu Chu
Publikováno v:
Cancer Science
Solute carrier family members control essential physiological functions and are tightly linked to human diseases. Solute carrier family 35 member F2 (SLC35F2) is aberrantly activated in several malignancies. However, the biological function and molec
Publikováno v:
BMC Urology
Background Bladder cancer (BC) is the 10th most common cancer in the UK, with about 10,000 new cases annually. About 75–85% of BC are non-muscle invasive (NMIBC), which is associated with high recurrence and progression rates (50–60% within 7–1
Autor:
Hinrich Abken, Michael Hudecek, Anna Christina Dragon, Barbara Uchanska-Ziegler, Caroline Mangare, Christina Kloth, Katharina Zimmermann, Axel Schambach, Thomas Nerreter, Sabine Tischer-Zimmermann, Julia Lahrberg, Stephan Klöß, Britta Eiz-Vesper, Rainer Blasczyk, Agnes Bonifacius, Britta Maecker-Kolhoff, Deborah Sandfort
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundImmunosuppressive therapy or T-cell depletion in transplant patients can cause uncontrolled growth of Epstein-Barr virus (EBV)-infected B cells resulting in post-transplant lymphoproliferative disease (PTLD). Current treatment options do no
Autor:
Andreas Rosenwald, Grzegorz Rymkiewicz, Anja Mottok, Michael Unterhalt, Sylvia Hartmann, Harald Holte, Lisa M. Rimsza, Eva Hoster, Christoph Thorns, German Ott, Martin Dreyling, David W. Scott, Wolfram Klapper, Hanneke C. Kluin-Nelemans, Hilka Rauert-Wunderlich, Olivier Hermine
Publikováno v:
British Journal of Haematology, 184(4), 616-624. Wiley
Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly variable. Established risk factors include the Mantle Cell Lymphoma International Prognostic Index (MIPI) and the quantification of the proliferation rat
Publikováno v:
Surgical oncology. 37
Introduction The rate of adrenal disease diagnosed is progressively increasing due to the diagnostic tools improvement. We analysed patients that underwent to adrenalectomy in our centre for different adrenal pathologies and we tried to established g
Autor:
Jeffrey E. Lee, Angelica M. Silva, Adam S. Garden, Elizabeth G. Grubbs, Ioannis Christakis, Mark Zafereo, Michelle D. Williams, Nancy D. Perrier, Naifa L. Busaidy
Publikováno v:
Practical Radiation Oncology. 7:e463-e470
Purpose We aimed to investigate outcomes of locoregional radiation therapy (XRT) in parathyroid carcinoma (PC) patients at a single institution over 35 years. Methods and materials Retrospective review of PC patients who received postoperative locore
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 143:2375-2382
Sublobar resection has been increasingly adopted in elderly patients with stage IA non-small cell lung cancer (NSCLC), but the equivalency of sublobar resection versus lobectomy among young patients with stage IA NSCLC is unknown. Using the Surveilla
Autor:
Xiaoying Liu, Jonathan D. Marotti, Camilo E. Fadul, Todd W. Miller, Vincent A. Memoli, Arief A. Suriawinata, Laura J. Tafe, Jason R. Pettus, Joel A. Lefferts, Ivan P. Gorlov, Clinton R. Morgan, Konstantin H. Dragnev, Britt M. Holderness, Jason D. Peterson, Gregory J. Tsongalis, Gary N. Schwartz, Mary D. Chamberlin, Francine B. de Abreu, Kasia J. Bloch
Publikováno v:
The Oncologist. 20:1011-1018
Background. Although genetic profiling of tumors is a potentially powerful tool to predict drug sensitivity and resistance, its routine use has been limited because clinicians are often unfamiliar with interpretation and incorporation of the informat